Evidence map›Paper›PMID 32056226›Full record

ReviewAlcoholism, clinical and experimental research2020

Interactions Between Alcohol and the Endocannabinoid System.

George Kunos

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Alcoholism, clinical and experimental research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Observational
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Striatonigral direct pathway 2-arachidonoylglycerol contributes to ethanol effects on synaptic transmission and behavior.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

George KunosFrom the, Division of Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland.ORCID 0000-0003-1788-4976
National Institutes of Health · US

Funding

Endocannabinoids And The Control Of Cardiovascular FunctionZIAAA000351 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI KUNOS, GEORGE · 2009 to 2025
$11.8M
Endocannabinoids And Appetitive FunctionsZ01AA000350 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI KUNOS, GEORGE · 2001 to 2008
$2.1M
Intramural NIH HHS Z01 AA000350
6 · The paper itself

Abstract

Endocannabinoids are lipid mediators that interact with the same cannabinoid receptors that recognize Δ

Indexed as

Alcohol DrinkingAlcoholismAnimalsBinge DrinkingCannabinoid Receptor AgonistsCannabinoid Receptor AntagonistsEndocannabinoidsEthanolHumansLipogenesisLiverLiver Diseases, AlcoholicMarijuana AbuseReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2Cannabinoid Receptor AgonistsCannabinoid Receptor AntagonistsEndocannabinoidsEthanolReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2Alcohol Drinking BehaviorAlcoholic Liver DiseaseCannabinoid ReceptorsEndocannabinoids

Identifiers

PMID32056226
PMCPMC8760843
OpenAlexW3006158295

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.